METHODS FOR TREATING CANCER WITH BAVITUXIMAB BASED ON LEVELS OF β2-GLYCOPROTEIN 1, AND… Application WO-2018064013-A1 World Intellectual Property Organisation (WIPO) 05 Apr 2018